NIH Asks Court To Dismiss KEI CAR-T Licensing Lawsuit

June 8, 2018 at 6:32 PM
The National Institutes of Health is asking a federal court to dismiss a lawsuit brought by Knowledge Ecology International challenging the agency’s plan to issue Kite Pharma an exclusive license to a government-developed CAR-T cancer therapy. In April KEI sued NIH in the federal district court of Maryland , alleging the agency violated the Administrative Procedure Act after NIH determined KEI could not appeal the agency's plan to issue the exclusive license. The group also alleged NIH violated the Federal...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.